VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $899,000 | -80.3% | 34,400 | -88.5% | 0.18% | -90.6% |
Q4 2017 | $4,560,000 | +708.5% | 300,000 | +344.4% | 1.91% | +645.3% |
Q1 2016 | $564,000 | -79.8% | 67,500 | -72.7% | 0.26% | -83.9% |
Q3 2015 | $2,792,000 | -25.8% | 247,500 | -19.5% | 1.59% | -17.3% |
Q2 2015 | $3,764,000 | +403.2% | 307,500 | +282.5% | 1.93% | +399.0% |
Q1 2015 | $748,000 | -76.8% | 80,383 | -64.3% | 0.39% | -67.4% |
Q4 2014 | $3,222,000 | – | 225,000 | – | 1.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |